domingo, 20 de septiembre de 2020

Three lessons from Covid-19 on accelerating biopharma innovation - STAT

Three lessons from Covid-19 on accelerating biopharma innovation - STAT

First Opinion

Three lessons from Covid-19 on accelerating biopharma innovation

By ANNE WHITE


ADOBE
Innovation in biopharma research and development being wrought by Covid-19 will improve R&D in cancer and other fields.

No hay comentarios: